Parikshit Nirbhay, Amar Ujala, New Delhi.
Published by: Yogesh Sahu
Updated Saturday, 18 December 2021 06:32 AM IST
An agreement has been reached between the National Technical Immunization Advisory Committee and the Empowered Group of the Central Government on corona vaccination for overdose. However, even after this extra dose is approved, there are still many obstacles to overcome.
Listen to the news
Even after this decision many obstacles have to be overcome. That is why the government is waiting everywhere. The omicron variant is waiting to be isolated in one step. On the other hand, the results of the initiated studies on Kovishield and Kovoxin have not even come yet.
A senior physician affiliated with the National Technical Immunization Advisory Committee said that almost all experts agreed to give an additional dose of the vaccine, but now we can not allow it because we have nothing about a third dose.
The Kovshield vaccine has been tested in the UK but has not yet been tested in India. An additional dose for covaxin is also working, but it is important to isolate the omicran variant for that. This work is being done by scientists at the National Institute of Virology (NIV) in Pune.
This process takes two to three weeks. In such a situation, experts are still waiting for its news from NIV. The senior doctor said that there are about 40 crore health workers and high risk population in the country and they have been selected for additional doses.